Physiomics presenting at BioTrinity

Physiomics announced on Friday that it would attend BioTrinity 2017, which the company described as “one of Europe's leading” biopartnering and investment conferences, to be held on 8-10 May at the Novotel London West.

The AIM-traded firm said, in addition t participating in a number of partnering meetings, Physiomics would present an update on its technology at the conference on 9 May.

CEO Dr Jim Millen would speak at 2430 BST during the Early Stage Showcase 4 session.

Founded and produced by OBN, BioTrinity was now in its 11th year.

Physiomics said the conference continued to grow, with more than 1,000 senior executives and decision makers from emerging and established companies across the life sciences sector and investment firms expected to attend.

“We are delighted that Physiomics will be presenting at BioTrinity this year,” said OBN CEN John Harris.

“BioTrinity is the perfect platform for life science companies to showcase their innovation and seek out their next deal.

“This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2017.”